| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |